A study lead by researchers from Mayo Clinic suggests remission from Crohn’s disease may be more likely if patients receive biologic therapy combined with immune-suppressing drugs first instead of ...

Here's part of interesting release that rolled out of Mayo Clinic this morning…before the communications office open. Somebody has learned how to automate. Heh. Centocor, Inc. is the company that ...

The Leona M. and Harry B. Helmsley Charitable Trust has awarded $5.3 million to Cleveland Clinic, Mayo Clinic and Alimentiv Inc. (a gastrointestinal contract research organization) in support of a ...

Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn's disease. People with IBD may experience persistent ...

In a randomized trial, 1 day of octreotide infusion combined with endoscopic therapy proved noninferior to 5 days for acute ...

“There’s currently no cure for Crohn’s disease. There are a variety of therapies but none that work for everyone. Your ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...

If you have an inflammatory bowel disease like ulcerative colitis or Crohn’s disease, liver disease can be a complication.